Population Health And EHR Integration Will Redefine Remote Cardiac Care

Published
26 May 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$178.75
10.2% undervalued intrinsic discount
15 Aug
US$160.58
Loading
1Y
130.5%
7D
0.01%

Author's Valuation

US$178.8

10.2% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on02 Aug 25
Fair value Increased 22%

The upward revision in iRhythm Technologies’ consensus price target reflects improved net profit margin and a substantially lower future P/E multiple, raising the fair value estimate from $146.83 to $159.83. What's in the News iRhythm Technologies issued full-year 2025 revenue guidance of $720–$730 million.